nodes	percent_of_prediction	percent_of_DWPC	metapath
Ouabain—CYP1A1—Clobetasol propionate—psoriasis	0.134	0.141	CbGbCtD
Ouabain—SLCO4C1—Methotrexate—psoriasis	0.0969	0.102	CbGbCtD
Ouabain—SLCO1B3—Mycophenolate mofetil—psoriasis	0.0947	0.0998	CbGbCtD
Ouabain—CYP1A1—Methoxsalen—psoriasis	0.0704	0.0742	CbGbCtD
Ouabain—SLCO1C1—Methotrexate—psoriasis	0.068	0.0717	CbGbCtD
Ouabain—SLCO1B1—Mycophenolate mofetil—psoriasis	0.0552	0.0581	CbGbCtD
Ouabain—SLCO1A2—Prednisolone—psoriasis	0.0495	0.0522	CbGbCtD
Ouabain—SLCO1A2—Hydrocortisone—psoriasis	0.0469	0.0495	CbGbCtD
Ouabain—SLCO1A2—Prednisone—psoriasis	0.0467	0.0493	CbGbCtD
Ouabain—CYP1A1—Cholecalciferol—psoriasis	0.0466	0.0492	CbGbCtD
Ouabain—SLCO1A2—Cyclosporine—psoriasis	0.0443	0.0467	CbGbCtD
Ouabain—SLCO1B1—Cyclosporine—psoriasis	0.0418	0.0441	CbGbCtD
Ouabain—SLCO1B3—Methotrexate—psoriasis	0.038	0.04	CbGbCtD
Ouabain—SLCO1A2—Dexamethasone—psoriasis	0.0292	0.0308	CbGbCtD
Ouabain—SLCO1A2—Methotrexate—psoriasis	0.0234	0.0247	CbGbCtD
Ouabain—SLCO1B1—Methotrexate—psoriasis	0.0221	0.0233	CbGbCtD
Ouabain—SLC22A8—Methotrexate—psoriasis	0.0204	0.0215	CbGbCtD
Ouabain—CYP1A1—Dexamethasone—psoriasis	0.0202	0.0213	CbGbCtD
Ouabain—KLF5—manus—psoriasis	0.0172	0.358	CbGeAlD
Ouabain—KLF5—manual digit—psoriasis	0.0168	0.35	CbGeAlD
Ouabain—KLF5—skin of body—psoriasis	0.00447	0.093	CbGeAlD
Ouabain—KLF5—tendon—psoriasis	0.0034	0.0708	CbGeAlD
Ouabain—CYP1A1—skin epidermis—psoriasis	0.00291	0.0605	CbGeAlD
Ouabain—ATP1A1—skin of body—psoriasis	0.00134	0.0278	CbGeAlD
Ouabain—ATP1A1—tendon—psoriasis	0.00102	0.0212	CbGeAlD
Ouabain—CYP1A1—skin of body—psoriasis	0.000901	0.0187	CbGeAlD
Ouabain—KLF5—Transcriptional regulation of white adipocyte differentiation—CARM1—psoriasis	0.000373	0.115	CbGpPWpGaD
Ouabain—KLF5—Transcriptional regulation of white adipocyte differentiation—LEP—psoriasis	0.000178	0.0547	CbGpPWpGaD
Ouabain—CYP1A1—Xenobiotics—CYP2S1—psoriasis	0.000166	0.051	CbGpPWpGaD
Ouabain—KLF5—Adipogenesis—SOCS1—psoriasis	0.000159	0.0488	CbGpPWpGaD
Ouabain—KLF5—Transcriptional regulation of white adipocyte differentiation—PPARG—psoriasis	0.000155	0.0477	CbGpPWpGaD
Ouabain—KLF5—Adipogenesis—LEP—psoriasis	0.000117	0.036	CbGpPWpGaD
Ouabain—KLF5—Transcriptional regulation of white adipocyte differentiation—NFKB1—psoriasis	0.000106	0.0326	CbGpPWpGaD
Ouabain—KLF5—Adipogenesis—PPARG—psoriasis	0.000102	0.0314	CbGpPWpGaD
Ouabain—SLCO1B1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	8.79e-05	0.027	CbGpPWpGaD
Ouabain—KLF5—Developmental Biology—CARM1—psoriasis	8.42e-05	0.0259	CbGpPWpGaD
Ouabain—KLF5—Transcriptional regulation of white adipocyte differentiation—TNF—psoriasis	8.24e-05	0.0253	CbGpPWpGaD
Ouabain—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	6.89e-05	0.0212	CbGpPWpGaD
Ouabain—CYP1A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	6.8e-05	0.0209	CbGpPWpGaD
Ouabain—KLF5—Adipogenesis—STAT3—psoriasis	6.26e-05	0.0192	CbGpPWpGaD
Ouabain—CYP1A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	5.59e-05	0.0172	CbGpPWpGaD
Ouabain—SLCO4C1—SLC-mediated transmembrane transport—CP—psoriasis	5.46e-05	0.0168	CbGpPWpGaD
Ouabain—KLF5—Adipogenesis—TNF—psoriasis	5.42e-05	0.0167	CbGpPWpGaD
Ouabain—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	5.05e-05	0.0155	CbGpPWpGaD
Ouabain—SLCO1C1—SLC-mediated transmembrane transport—CP—psoriasis	4.58e-05	0.0141	CbGpPWpGaD
Ouabain—KLF5—Adipogenesis—IL6—psoriasis	4.37e-05	0.0134	CbGpPWpGaD
Ouabain—KLF5—Developmental Biology—LEP—psoriasis	4.03e-05	0.0124	CbGpPWpGaD
Ouabain—CYP1A1—Oxidative Stress—CAT—psoriasis	3.6e-05	0.0111	CbGpPWpGaD
Ouabain—KLF5—Developmental Biology—PPARG—psoriasis	3.51e-05	0.0108	CbGpPWpGaD
Ouabain—CYP1A1—Estrogen Receptor Pathway—JUN—psoriasis	3.38e-05	0.0104	CbGpPWpGaD
Ouabain—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	3.31e-05	0.0102	CbGpPWpGaD
Ouabain—KLF5—Developmental Biology—TYK2—psoriasis	3.07e-05	0.00945	CbGpPWpGaD
Ouabain—CYP1A1—Biological oxidations—CYP2S1—psoriasis	2.97e-05	0.00912	CbGpPWpGaD
Ouabain—CYP1A1—Metapathway biotransformation—CYP2S1—psoriasis	2.93e-05	0.009	CbGpPWpGaD
Ouabain—CYP1A1—Estrogen Receptor Pathway—STAT3—psoriasis	2.92e-05	0.00898	CbGpPWpGaD
Ouabain—CYP1A1—Melatonin metabolism and effects—APOE—psoriasis	2.88e-05	0.00885	CbGpPWpGaD
Ouabain—SLCO4C1—Transmembrane transport of small molecules—CP—psoriasis	2.78e-05	0.00853	CbGpPWpGaD
Ouabain—SLCO4C1—Transmembrane transport of small molecules—CARM1—psoriasis	2.65e-05	0.00814	CbGpPWpGaD
Ouabain—SLCO1B3—SLC-mediated transmembrane transport—CP—psoriasis	2.59e-05	0.00797	CbGpPWpGaD
Ouabain—CYP1A1—Tryptophan metabolism—CAT—psoriasis	2.56e-05	0.00787	CbGpPWpGaD
Ouabain—KLF5—Developmental Biology—NFKB1—psoriasis	2.39e-05	0.00736	CbGpPWpGaD
Ouabain—SLCO1C1—Transmembrane transport of small molecules—CP—psoriasis	2.33e-05	0.00715	CbGpPWpGaD
Ouabain—ATP1A1—Transmembrane transport of small molecules—CP—psoriasis	2.33e-05	0.00715	CbGpPWpGaD
Ouabain—SLC22A8—SLC-mediated transmembrane transport—CP—psoriasis	2.29e-05	0.00705	CbGpPWpGaD
Ouabain—ATP1A1—Transmembrane transport of small molecules—CARM1—psoriasis	2.22e-05	0.00682	CbGpPWpGaD
Ouabain—SLCO1C1—Transmembrane transport of small molecules—CARM1—psoriasis	2.22e-05	0.00682	CbGpPWpGaD
Ouabain—KLF5—Developmental Biology—VEGFA—psoriasis	2.17e-05	0.00668	CbGpPWpGaD
Ouabain—KLF5—Developmental Biology—STAT3—psoriasis	2.15e-05	0.00661	CbGpPWpGaD
Ouabain—CYP1A1—PPARA activates gene expression—CARM1—psoriasis	2.07e-05	0.00637	CbGpPWpGaD
Ouabain—SLCO1A2—SLC-mediated transmembrane transport—CP—psoriasis	2.04e-05	0.00626	CbGpPWpGaD
Ouabain—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	2.03e-05	0.00623	CbGpPWpGaD
Ouabain—KLF5—Developmental Biology—TNF—psoriasis	1.86e-05	0.00573	CbGpPWpGaD
Ouabain—SLCO1B1—SLC-mediated transmembrane transport—CP—psoriasis	1.74e-05	0.00535	CbGpPWpGaD
Ouabain—CYP1A1—Melatonin metabolism and effects—NFKB1—psoriasis	1.71e-05	0.00526	CbGpPWpGaD
Ouabain—CYP1A1—Oxidative Stress—NFKB1—psoriasis	1.67e-05	0.00512	CbGpPWpGaD
Ouabain—KLF5—Developmental Biology—IL6—psoriasis	1.5e-05	0.00462	CbGpPWpGaD
Ouabain—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	1.42e-05	0.00437	CbGpPWpGaD
Ouabain—SLCO1B3—Metabolism—NDUFA5—psoriasis	1.42e-05	0.00436	CbGpPWpGaD
Ouabain—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	1.4e-05	0.0043	CbGpPWpGaD
Ouabain—SLCO1B3—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.32e-05	0.00406	CbGpPWpGaD
Ouabain—SLCO1B3—Transmembrane transport of small molecules—CP—psoriasis	1.32e-05	0.00405	CbGpPWpGaD
Ouabain—SLCO1B3—Transmembrane transport of small molecules—CARM1—psoriasis	1.26e-05	0.00386	CbGpPWpGaD
Ouabain—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	1.23e-05	0.00378	CbGpPWpGaD
Ouabain—SLCO1B3—Metabolism—CYP2S1—psoriasis	1.21e-05	0.0037	CbGpPWpGaD
Ouabain—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	1.18e-05	0.00364	CbGpPWpGaD
Ouabain—SLC22A8—Transmembrane transport of small molecules—CP—psoriasis	1.17e-05	0.00358	CbGpPWpGaD
Ouabain—SLCO1A2—Metabolism—NDUFA5—psoriasis	1.11e-05	0.00342	CbGpPWpGaD
Ouabain—SLC22A8—Transmembrane transport of small molecules—CARM1—psoriasis	1.11e-05	0.00342	CbGpPWpGaD
Ouabain—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	1.07e-05	0.0033	CbGpPWpGaD
Ouabain—SLCO1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.04e-05	0.00319	CbGpPWpGaD
Ouabain—SLCO1A2—Transmembrane transport of small molecules—CP—psoriasis	1.03e-05	0.00318	CbGpPWpGaD
Ouabain—SLCO1A2—Transmembrane transport of small molecules—CARM1—psoriasis	9.87e-06	0.00303	CbGpPWpGaD
Ouabain—SLCO1B1—Metabolism—NDUFA5—psoriasis	9.52e-06	0.00293	CbGpPWpGaD
Ouabain—SLCO1A2—Metabolism—CYP2S1—psoriasis	9.47e-06	0.00291	CbGpPWpGaD
Ouabain—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	9.2e-06	0.00283	CbGpPWpGaD
Ouabain—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriasis	9.2e-06	0.00283	CbGpPWpGaD
Ouabain—SLCO1B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	8.88e-06	0.00273	CbGpPWpGaD
Ouabain—SLCO1B1—Transmembrane transport of small molecules—CP—psoriasis	8.85e-06	0.00272	CbGpPWpGaD
Ouabain—CYP1A1—PPARA activates gene expression—PPARG—psoriasis	8.63e-06	0.00265	CbGpPWpGaD
Ouabain—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	8.44e-06	0.0026	CbGpPWpGaD
Ouabain—SLCO1B1—Transmembrane transport of small molecules—CARM1—psoriasis	8.44e-06	0.0026	CbGpPWpGaD
Ouabain—SLCO1B1—Metabolism—CYP2S1—psoriasis	8.1e-06	0.00249	CbGpPWpGaD
Ouabain—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.32e-06	0.00194	CbGpPWpGaD
Ouabain—CYP1A1—Metabolism—NDUFA5—psoriasis	5.97e-06	0.00183	CbGpPWpGaD
Ouabain—SLCO1B3—Metabolism—CARM1—psoriasis	5.89e-06	0.00181	CbGpPWpGaD
Ouabain—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	5.82e-06	0.00179	CbGpPWpGaD
Ouabain—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.57e-06	0.00171	CbGpPWpGaD
Ouabain—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.5e-06	0.00169	CbGpPWpGaD
Ouabain—CYP1A1—Metabolism—CYP2S1—psoriasis	5.08e-06	0.00156	CbGpPWpGaD
Ouabain—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.96e-06	0.00153	CbGpPWpGaD
Ouabain—SLCO1A2—Metabolism—CARM1—psoriasis	4.62e-06	0.00142	CbGpPWpGaD
Ouabain—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.32e-06	0.00133	CbGpPWpGaD
Ouabain—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.24e-06	0.0013	CbGpPWpGaD
Ouabain—SLCO1B1—Metabolism—CARM1—psoriasis	3.95e-06	0.00122	CbGpPWpGaD
Ouabain—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.7e-06	0.00114	CbGpPWpGaD
Ouabain—SLCO1B3—Metabolism—CAT—psoriasis	3.62e-06	0.00111	CbGpPWpGaD
Ouabain—SLCO1A2—Metabolism—CAT—psoriasis	2.84e-06	0.000874	CbGpPWpGaD
Ouabain—SLCO1B3—Metabolism—APOE—psoriasis	2.81e-06	0.000865	CbGpPWpGaD
Ouabain—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.66e-06	0.000818	CbGpPWpGaD
Ouabain—CYP1A1—Metabolism—CARM1—psoriasis	2.48e-06	0.000762	CbGpPWpGaD
Ouabain—SLCO1B3—Metabolism—PPARG—psoriasis	2.45e-06	0.000753	CbGpPWpGaD
Ouabain—SLCO1B1—Metabolism—CAT—psoriasis	2.43e-06	0.000748	CbGpPWpGaD
Ouabain—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.32e-06	0.000712	CbGpPWpGaD
Ouabain—SLCO1A2—Metabolism—APOE—psoriasis	2.21e-06	0.000679	CbGpPWpGaD
Ouabain—SLCO1A2—Metabolism—PPARG—psoriasis	1.92e-06	0.000592	CbGpPWpGaD
Ouabain—SLCO1B1—Metabolism—APOE—psoriasis	1.89e-06	0.000581	CbGpPWpGaD
Ouabain—SLCO1B1—Metabolism—PPARG—psoriasis	1.65e-06	0.000506	CbGpPWpGaD
Ouabain—CYP1A1—Metabolism—CAT—psoriasis	1.52e-06	0.000469	CbGpPWpGaD
Ouabain—CYP1A1—Metabolism—APOE—psoriasis	1.18e-06	0.000364	CbGpPWpGaD
Ouabain—CYP1A1—Metabolism—PPARG—psoriasis	1.03e-06	0.000317	CbGpPWpGaD
